Effects of Action Observation Therapy and Mirror Therapy in Children With Unilateral Cerebral Palsy

July 10, 2023 updated by: SEDANUR GÜRLEK, Hacettepe University

Effects of Action Observation Therapy and Mirror Therapy on Upper Extremity Functions in Children With Unilateral Cerebral Palsy: A Randomized Controlled Study With 1 Month Follow-Up

The aim of this study was to examine the effects of action observation therapy and mirror therapy on upper extremity functions in children with unilateral cerebral palsy. In the study, the 1st group is the Action Observation Therapy group and will receive 18 sessions of practice. The second group is the mirror therapy group and will receive a total of 18 practice sessions. To evaluate the outcome measures of children's upper extremity functions; Canadian Occupational Performance Mesure (COPM), Goal Achievement Scale (GAS), Shriners Hospital Upper Extremity Function Scale (SHUEE), Melbourne Unilateral Upper Extremity Function Evaluation Test and ABILHAND Questionnaire will be used. The satisfaction of the families with the therapy process will be evaluated with the Visual Analog Scale (VAS).

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The aim of this study was to examine the effects of action observation therapy and mirror therapy on upper extremity functions in children with unilateral cerebral palsy. In the study, the 1st group is the Action Observation Therapy group and will receive 18 sessions of practice. The second group is the mirror therapy group and will receive a total of 18 practice sessions. To evaluate the outcome measures of children's upper extremity functions; Canadian Occupational Performance Mesure (COPM), Goal Achievement Scale (GAS), Shriners Hospital Upper Extremity Function Scale (SHUEE), Melbourne Unilateral Upper Extremity Function Evaluation Test and ABILHAND Questionnaire will be used. The satisfaction of the families with the therapy process will be evaluated with the Visual Analog Scale (VAS).

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being between the ages of 5 and 15
  • Being diagnosed with unilateral cerebral palsy
  • Be in one of the levels 1,2 and 3 according to the MACS dexterity classification
  • Upper extremity Modified Ashworth Scale score less than or equal to 2 attending primary school

Exclusion Criteria:

  • Having a visual impairment recorded in the health report
  • To have any neurological, orthopedic, and psychiatric diagnosis in addition to the diagnosis of cerebral palsy
  • Difficulty understanding and applying verbal and visual commands
  • To have undergone any surgical intervention or botox in the last 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Cerebral Palsy
Other: Action Observation Therapy
Action Observation Therapy Mirror Therapy
Other Names:
  • Mirror Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Canadian Occupational Performance Measure
Time Frame: 6 weeks
Assessment
6 weeks
Goal Attainment Scaling
Time Frame: 6 weeks
Assessment
6 weeks
Shriners Hospital Upper Extremity Evaluation
Time Frame: 6 weeks
Assessment
6 weeks
Melbourne Assessment of Unilateral Upper Limb Function
Time Frame: 6 weeks
Assessment
6 weeks
ABILHAND-Kids Questionnaire
Time Frame: 6 weeks
Assessment
6 weeks
Visual Analogue Scale
Time Frame: 6 weeks
Assessment
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 10, 2023

Primary Completion (Estimated)

January 10, 2025

Study Completion (Estimated)

January 15, 2025

Study Registration Dates

First Submitted

June 21, 2023

First Submitted That Met QC Criteria

July 10, 2023

First Posted (Actual)

July 19, 2023

Study Record Updates

Last Update Posted (Actual)

July 19, 2023

Last Update Submitted That Met QC Criteria

July 10, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SG13

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Action Observation Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe